Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Research Site
mi
from
Dayton, OH
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Research Site
mi
from
Dayton, OH
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Study Site
mi
from
Oklahoma City, OK
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Study Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Allentown, PA
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Allentown, PA
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Norristown, PA
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Norristown, PA
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Philadelphia, PA
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Memphis, TN
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Memphis, TN
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Austin, TX
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Austin, TX
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Dallas, TX
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Houston, TX
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Houston, TX
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Everett, WA
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Everett, WA
Click here to add this to my saved trials
An Study of Transcranial Direct Current Stimulation in Adults With ADHD
An Open Label Pilot Study of Transcranial Direct Current Stimulation in Adults With ADHD
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
An Study of Transcranial Direct Current Stimulation in Adults With ADHD
An Open Label Pilot Study of Transcranial Direct Current Stimulation in Adults With ADHD
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) Study
Cerebellar Transcranial Magnetic Stimulation (cTMS) in Psychotic Disorders: Effect on Time Perception, Executive Function, and Mood and Psychotic Symptoms
Status: Enrolling
Updated:  12/31/1969
McLean Hospital
mi
from
Belmont, MA
Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) Study
Cerebellar Transcranial Magnetic Stimulation (cTMS) in Psychotic Disorders: Effect on Time Perception, Executive Function, and Mood and Psychotic Symptoms
Status: Enrolling
Updated: 12/31/1969
McLean Hospital
mi
from
Belmont, MA
Click here to add this to my saved trials
Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) Study
Cerebellar Transcranial Magnetic Stimulation (cTMS) in Psychotic Disorders: Effect on Time Perception, Executive Function, and Mood and Psychotic Symptoms
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Charlestown, MA
Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) Study
Cerebellar Transcranial Magnetic Stimulation (cTMS) in Psychotic Disorders: Effect on Time Perception, Executive Function, and Mood and Psychotic Symptoms
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Charlestown, MA
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Southwest Autism Research and Resource Center (SARRC)
mi
from
Phoenix, AZ
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Southwest Autism Research and Resource Center (SARRC)
mi
from
Phoenix, AZ
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Arkansas Children'S Hosp. Research Institute (A.C.H.R.I.)
mi
from
Little Rock, AR
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Arkansas Children'S Hosp. Research Institute (A.C.H.R.I.)
mi
from
Little Rock, AR
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
NRC Research Institute
mi
from
Orange, CA
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
NRC Research Institute
mi
from
Orange, CA
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Mind Institute (Univ.of California, Davis)
mi
from
Sacramento, CA
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Mind Institute (Univ.of California, Davis)
mi
from
Sacramento, CA
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
University of California, UCSF
mi
from
San Francisco, CA
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
University of California, UCSF
mi
from
San Francisco, CA
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
APG Research, LLC
mi
from
Orlando, FL
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
APG Research, LLC
mi
from
Orlando, FL
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
LSU Health Sciences Center
mi
from
Shreveport, LA
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
LSU Health Sciences Center
mi
from
Shreveport, LA
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Detroit Clinical Research Center, P.C.
mi
from
Bingham Farms, MI
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Detroit Clinical Research Center, P.C.
mi
from
Bingham Farms, MI
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Lovelace Scientific Resources, Inc.
mi
from
Albuquerque, NM
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Lovelace Scientific Resources, Inc.
mi
from
Albuquerque, NM
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Montefiore Med.Cneter, Autism & Obsessive Compulsive Spectrum Program
mi
from
Bronx, NY
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Montefiore Med.Cneter, Autism & Obsessive Compulsive Spectrum Program
mi
from
Bronx, NY
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Richmond Behavioral Associates
mi
from
Staten Island, NY
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Richmond Behavioral Associates
mi
from
Staten Island, NY
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Duke Center for Autism and Brain Development
mi
from
Durham, NC
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Duke Center for Autism and Brain Development
mi
from
Durham, NC
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic Autism Center
mi
from
Cleveland, OH
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Autism Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Omega Medical Research
mi
from
Warwick, RI
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Omega Medical Research
mi
from
Warwick, RI
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Vanderbilt Universtiy Med.Center-Treatment&Research Inst. For Asd
mi
from
Nashville, TN
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Vanderbilt Universtiy Med.Center-Treatment&Research Inst. For Asd
mi
from
Nashville, TN
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
University of Texas, Houston-Behavioral & Biomedical Sciences
mi
from
Houston, TX
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
University of Texas, Houston-Behavioral & Biomedical Sciences
mi
from
Houston, TX
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Carilion Clinic-Virginia Tech, Carilion School of Medicine
mi
from
Roanoke, VA
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Carilion Clinic-Virginia Tech, Carilion School of Medicine
mi
from
Roanoke, VA
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
University of Arizona, Pediatrics Multidisciplinary Research Unit
mi
from
Tucson, AZ
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
University of Arizona, Pediatrics Multidisciplinary Research Unit
mi
from
Tucson, AZ
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
IMMUNOe Research Centers
mi
from
Centennial, CO
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
IMMUNOe Research Centers
mi
from
Centennial, CO
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Yale Child Study Center
mi
from
New Haven, CT
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Yale Child Study Center
mi
from
New Haven, CT
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Research Institute of Deaconess Clinic
mi
from
Newburgh, IN
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Research Institute of Deaconess Clinic
mi
from
Newburgh, IN
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Lake Charles Clinical Trials LLC
mi
from
Lake Charles, LA
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Lake Charles Clinical Trials LLC
mi
from
Lake Charles, LA
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Clinical Research Center of NJ
mi
from
Voorhees, NJ
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Clinical Research Center of NJ
mi
from
Voorhees, NJ
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Carolina Clinical Trials, Inc.
mi
from
Charleston, SC
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Carolina Clinical Trials, Inc.
mi
from
Charleston, SC
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
NeuroScience, Inc.
mi
from
Herndon, VA
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
NeuroScience, Inc.
mi
from
Herndon, VA
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
University of Virginia, Dept. of Psychiatry and Neurobehavioral Sciences
mi
from
Charlottesville, VA
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
University of Virginia, Dept. of Psychiatry and Neurobehavioral Sciences
mi
from
Charlottesville, VA
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
The Segal Institute of Clinical Research
mi
from
North Miami, FL
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
The Segal Institute of Clinical Research
mi
from
North Miami, FL
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Children'S Specialized Hospital
mi
from
Egg Harbor Township, NJ
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Children'S Specialized Hospital
mi
from
Egg Harbor Township, NJ
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Florida Hospital Medical Group-Lake Mary Pediatrics
mi
from
Orange City, FL
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Florida Hospital Medical Group-Lake Mary Pediatrics
mi
from
Orange City, FL
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Children's Specialized Hospital
mi
from
Toms River, NJ
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Children's Specialized Hospital
mi
from
Toms River, NJ
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated:  12/31/1969
Focus Center of Clinical Research
mi
from
Clinton, UT
An Open Label Study of CM-AT for the Treatment of Children With Autism
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Focus Center of Clinical Research
mi
from
Clinton, UT
Click here to add this to my saved trials
Prevention of Delirium in Inpatients Utilizing Melatonin
Prevention of Delirium in Inpatients Utilizing Melatonin
Status: Enrolling
Updated:  12/31/1969
Yale-New Haven Hospital—Saint Raphael Campus
mi
from
New Haven, CT
Prevention of Delirium in Inpatients Utilizing Melatonin
Prevention of Delirium in Inpatients Utilizing Melatonin
Status: Enrolling
Updated: 12/31/1969
Yale-New Haven Hospital—Saint Raphael Campus
mi
from
New Haven, CT
Click here to add this to my saved trials
Rostral Dorsal Cingulum Bundle Connectivity in Patients With Bipolar Disorder
Rostral Dorsal Cingulum Bundle Connectivity in Patients With Bipolar Disorder
Status: Enrolling
Updated:  12/31/1969
University Hospitals of Cleveland Medical Center
mi
from
Cleveland, OH
Rostral Dorsal Cingulum Bundle Connectivity in Patients With Bipolar Disorder
Rostral Dorsal Cingulum Bundle Connectivity in Patients With Bipolar Disorder
Status: Enrolling
Updated: 12/31/1969
University Hospitals of Cleveland Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Immediate Postpartum Nexplanon Placement in Opioid Dependent Women
A Prospective Observational Clinical Trial to Compare the Effect of Immediate Postpartum Nexplanon Placement Versus Standard Postpartum Contraceptive Care on Consistent Contraceptive Use and Rapid Repeat Pregnancy in Opioid Dependent Women.
Status: Enrolling
Updated:  12/31/1969
Magee-Womens Hospital of UPMC
mi
from
Pittsburgh, PA
Immediate Postpartum Nexplanon Placement in Opioid Dependent Women
A Prospective Observational Clinical Trial to Compare the Effect of Immediate Postpartum Nexplanon Placement Versus Standard Postpartum Contraceptive Care on Consistent Contraceptive Use and Rapid Repeat Pregnancy in Opioid Dependent Women.
Status: Enrolling
Updated: 12/31/1969
Magee-Womens Hospital of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Mental Stress Ischemia: Biofeedback Study
Effects of Biofeedback on Myocardial Blood Flow Changes During Mental Stress in Patients With Coronary Artery Disease
Status: Enrolling
Updated:  12/31/1969
Emory University Hospital
mi
from
Atlanta, GA
Mental Stress Ischemia: Biofeedback Study
Effects of Biofeedback on Myocardial Blood Flow Changes During Mental Stress in Patients With Coronary Artery Disease
Status: Enrolling
Updated: 12/31/1969
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Mental Stress Ischemia: Biofeedback Study
Effects of Biofeedback on Myocardial Blood Flow Changes During Mental Stress in Patients With Coronary Artery Disease
Status: Enrolling
Updated:  12/31/1969
Emory University
mi
from
Atlanta, GA
Mental Stress Ischemia: Biofeedback Study
Effects of Biofeedback on Myocardial Blood Flow Changes During Mental Stress in Patients With Coronary Artery Disease
Status: Enrolling
Updated: 12/31/1969
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Mental Stress Ischemia: Biofeedback Study
Effects of Biofeedback on Myocardial Blood Flow Changes During Mental Stress in Patients With Coronary Artery Disease
Status: Enrolling
Updated:  12/31/1969
Rollins School of Public Health
mi
from
Atlanta, GA
Mental Stress Ischemia: Biofeedback Study
Effects of Biofeedback on Myocardial Blood Flow Changes During Mental Stress in Patients With Coronary Artery Disease
Status: Enrolling
Updated: 12/31/1969
Rollins School of Public Health
mi
from
Atlanta, GA
Click here to add this to my saved trials